Emvision Medical Devices Ltd has released a press release.
AGM CEO Presentation including Latest Imaging Case Studies
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
In the deck
Story so far
Earlier from EMvision Medical Devices
- AGM Chairman's Address
- Gen 2 Advanced Prototype Assembled
- Encouraging Interim Clinical Trial Results
- Appendix 4E & Annual Report to 30 June 2023
- Latest Imaging and Clinical Trial Insights
Later from EMvision Medical Devices
- Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
- EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
- Strategic A$15.28M Investment from Keysight Technologies
- ASA Milestone Achieved for $0.6m Grant Payment
- Stage 2 Insights Confirm Diagnostic & Clinical Viability
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices